Chinook Therapeutics, Inc. (KDNY) Misses Q1 EPS by 6c

Chinook Therapeutics, Inc. (NASDAQ: KDNY) reported Q1 EPS of ($0.85), $0.06 worse than the analyst estimate of ($0.79). Revenue for the quarter came in at $1.83 million versus the consensus estimate of $300 thousand.

For earnings history and earnings-related data on Chinook Therapeutics, Inc. (KDNY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c